We are live on
!
Find out more
PCM
Palouse Capital Management Portfolio holdings
AUM
$160M
1-Year Est. Return
36.15%
This Fund
S&P 500
This Quarter
Est. Return
+3.92%
1 Year Est. Return
+36.15%
3 Year Est. Return
+67.75%
5 Year Est. Return
+68.17%
10 Year Est. Return
+160.38%
AUM
$152M
AUM Growth
+$5.07M
(+3.5%)
Cap. Flow
-$189K
Cap. Flow
% of AUM
-0.12%
Top 10 Holdings %
Top 10 Hldgs %
29.29%
Holding
146
New
10
Increased
35
Reduced
45
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$5.12M |
| 2 |
Alexandria Real Estate Equities
ARE
|
+$2.73M |
| 3 |
Oneok
OKE
|
+$2.59M |
| 4 |
BA.PRA
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
|
+$2.51M |
| 5 |
Becton Dickinson
BDX
|
+$1.54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Keurig Dr Pepper
KDP
|
+$3.69M |
| 2 |
Air Products & Chemicals
APD
|
+$3.58M |
| 3 |
Kenvue
KVUE
|
+$2.27M |
| 4 |
IPG
Interpublic Group of Companies
IPG
|
+$1.49M |
| 5 |
Pfizer
PFE
|
+$1.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.98% |
| 2 | Healthcare | 12.53% |
| 3 | Financials | 12.28% |
| 4 | Communication Services | 7.97% |
| 5 | Consumer Staples | 7.9% |
Similar funds
MWM
PCC
CF
SGCM
RCWM
LCA
WHCI
FPWM
Palouse Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, Palouse Capital Management held 146 positions worth $152M, up 3.5% from $147M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Palouse Capital Management's Q2 2025 filing shows 10 new, 35 increased, 45 reduced and 18 closed positions. Its largest new stake was Alexandria Real Estate Equities: 36,754 shares worth $2.67M. The largest sale was Keurig Dr Pepper, an estimated $3.69M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- Palouse Capital Management's largest Q2 2025 buy was Alexandria Real Estate Equities: 36,754 shares worth $2.67M.
- Palouse Capital Management added most to UnitedHealth in Q2 2025, an estimated $5.12M increase.
- Palouse Capital Management's biggest Q2 2025 reduction was Pfizer, cutting an estimated $1.07M.
- Palouse Capital Management fully exited Keurig Dr Pepper in Q2 2025, selling an estimated $3.69M.
- Palouse Capital Management's ten largest holdings make up 29% of its $152M portfolio in Q2 2025.
- Palouse Capital Management opened 10 new positions and closed 18 in Q2 2025.
- Palouse Capital Management's portfolio value rose 3.5% quarter-over-quarter to $152M.
Based on Palouse Capital Management's 13F filing for Q2 2025, filed 7 Aug 2025.